Algert Global LLC Sutro Biopharma, Inc. Transaction History

Algert Global LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.92 - $5.33 $31,921 - $58,267	-10,932 Reduced 46.01%	12,829 $38,000
Q1 2024 May 14, 2024	BUY	$3.27 - $5.65 $77,698 - $134,249	23,761 New	23,761 $134,000
Q2 2023 Aug 14, 2023	SELL	$4.25 - $5.88 $141,482 - $195,745	-33,290 Reduced 73.1%	12,250 $57,000
Q1 2023 May 12, 2023	BUY	$4.48 - $8.45 $204,019 - $384,812	45,540 New	45,540 $210,000
Q2 2022 Aug 15, 2022	SELL	$3.41 - $8.95 $75,664 - $198,591	-22,189 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.78 - $15.31 $62,807 - $123,597	-8,073 Reduced 26.68%	22,189 $182,000
Q4 2021 Feb 14, 2022	SELL	$14.25 - $23.53 $55,432 - $91,531	-3,890 Reduced 11.39%	30,262 $450,000
Q3 2021 Nov 15, 2021	BUY	$16.88 - $22.38 $195,841 - $259,652	11,602 Added 51.45%	34,152 $645,000
Q2 2021 Aug 13, 2021	SELL	$18.03 - $23.82 $419,017 - $553,576	-23,240 Reduced 50.75%	22,550 $419,000
Q1 2021 May 14, 2021	SELL	$20.29 - $27.54 $374,553 - $508,388	-18,460 Reduced 28.73%	45,790 $1.04 Million
Q4 2020 Feb 12, 2021	BUY	$10.16 - $23.98 $652,780 - $1.54 Million	64,250 New	64,250 $1.4 Million

138

61.6M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $93.4M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.